AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 275: H378-H384, 1998;
0363-6135/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weil, J.
Right arrow Articles by Scholz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weil, J.
Right arrow Articles by Scholz, H.
Vol. 275, Issue 2, H378-H384, August 1998

Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium

Joachim Weil, Thomas Eschenhagen, Gerrit Fleige, Clemens Mittmann, Ellen Orthey, and Hasso Scholz

Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, D-20246 Hamburg, Germany

The enkephalins are derived from a common precursor protein known as preproenkephalin (ppENK). Enkephalins appear to be one of the endogenous ligands for the opiate receptors. In the rat the ventricular myocardium contains more ppENK mRNA than any other tissue. To gain further insight into the role of cardiac enkephalins, the regional and developmental distribution of ppENK mRNA was studied by Northern blotting and in situ hybridization. In the early postnatal period, ppENK mRNA is low in atrial and ventricular myocardium. With maturation, ppENK expression increases threefold in left and right ventricular tissue, but not in the atria or cardiac conductive system. Interestingly, ppENK mRNA levels are four times higher in the left than in the right chamber. Thus, to our knowledge, ppENK is the only gene exhibiting marked differences in expression between the adult right and left ventricle. Given the left-side preference of ppENK expression, the possibility is raised that the left ventricle is an endocrine organ that supplies the body with enkephalins.

in situ hybridization; endogenous opioids; gene expression; aging


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. H. Patel, B. P. Head, H. N. Petersen, I. R. Niesman, D. Huang, G. J. Gross, P. A. Insel, and D. M. Roth
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and {delta}-opioid receptors
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H344 - H350.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. H. Patel, A. Hsu, and G. J. Gross
Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2011 - H2017.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Fryer, Y. Wang, A. K. Hsu, and G. J. Gross
Essential activation of PKC-{delta} in opioid-initiated cardioprotection
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1346 - H1353.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. FINK, S. ERGÜN, D. KRALISCH, U. REMMERS, J. WEIL, and T. ESCHENHAGEN
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement
FASEB J, April 1, 2000; 14(5): 669 - 679.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. H. Patel, A. Hsu, and G. J. Gross
Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2011 - H2017.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online